Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Journal of Cancer

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejca.2015.06.123PMID 26271204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.

  2014cited by this paper
• The Influence of Sex, Ethnicity, and CYP2B6 Genotype on Bupropion Metabolism as an Index of Hepatic CYP2B6 Activity in Humans

  2013cited by this paper
• Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.

  2013cited by this paper
• Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

  2013cited by this paper
• Cytostatic drugs in infants: a review on pharmacokinetic data in infants.

  2012cited by this paper
• Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia

  2011cited by this paper
• Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: Report of the ALCL99 randomised trial

  2011cited by this paper
• Sex Disparities in Cancer Mortality and Survival

  2011cited by this paper
• Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism

  2010cited by this paper
• Activation of Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) by Herbal Medicines

  2009cited by this paper
• Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study

  2009cited by this paper
• Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

  2008cited by this paper
• Pharmacogenetics of the constitutive androstane receptor.

  2008cited by this paper
• Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver

  2008cited by this paper
• The Effect of Repeated Administration of Cyclophosphamide on Cytochrome P450 2B in Rats

  2007cited by this paper
• Expression of Constitutive Androstane Receptor, Hepatic Nuclear Factor 4α, and P450 Oxidoreductase Genes Determines Interindividual Variability in Basal Expression and Activity of a Broad Scope of Xenobiotic Metabolism Genes in the Human Liver

  2007cited by this paper
• The pheromone androstenol (5 alpha-androst-16-en-3 alpha-ol) is a neurosteroid positive modulator of GABAA receptors.

  2006cited by this paper
• The Pheromone Androstenol (5α-Androst-16-en-3α-ol) Is a Neurosteroid Positive Modulator of GABAA Receptors

  2006cited by this paper
• Synthetic Drugs and Natural Products as Modulators of Constitutive Androstane Receptor (Car) and Pregnane X Receptor (PXR)

  2006cited by this paper
• Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO‐E.W.I.N.G. 99 clinical trial

  2006cited by this paper
• Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression

  2003cited by this paper
• Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

  2003cited by this paper
• Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.

  2003cited by this paper
• Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels.

  2003cited by this paper
• Statistical analysis of correlated data using generalized estimating equations: an orientation.

  2003cited by this paper
• A solution to the problem of separation in logistic regression

  2002cited by this paper
• On functional misspecification of covariates in the Cox regression model

  2001cited by this paper
• Ewing Tumour

  2001cited by this paper
• Gender difference in ifosfamide metabolism by human liver microsomes

  2001cited by this paper
• Comparative biosynthetic pathway of androstenol and androgens.

  2001cited by this paper
• Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo.

  1998cited by this paper
• Androstane metabolites bind to and deactivate the nuclear receptor CAR-β

  1998cited by this paper
• Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines.

  1997cited by this paper
• Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.

  1992cited by this paper
• Effect of age and gender on the activity of human hepatic CYP3A.

  1992cited by this paper
• 16-Ene-steroids in the human testis.

  1991cited by this paper
• The loss in efficiency from misspecifying covariates in proportional hazards regression models

  1988cited by this paper

• Impact of sex on chemotherapy toxicity and efficacy in biliary tract cancer: analysis of ABC, BILCAP trials and population data

  2026cites this paper
• Sex differences in toxicity and outcomes in patients with sarcoma treated in the perioperative setting at a comprehensive cancer center

  2025cites this paper
• Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials

  2024influential citation
• Ifosfamide - History, efficacy, toxicity and encephalopathy.

  2023cites this paper
• The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial

  2023cites this paper
• Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial.

  2023cites this paper
• An evaluation of cancer aging research group (CARG) score to predict chemotherapy toxicity in older Iranian patients with cancer

  2023cites this paper
• Cellular Indoctrination: How the Tumor Microenvironment Reeducates Macrophages Towards Nefarious Ends

  2021cites this paper
• Obesity and Dose of Anti-cancer Therapy: Are We Sure to Be on the Right Track in the Precision Medicine Era?

  2021cites this paper
• Assessment of Risk of Bias in Osteosarcoma and Ewing’s Sarcoma Randomized Controlled Trials: A Systematic Review

  2021cites this paper
• Possible Mechanisms of Subsequent Neoplasia Development in Childhood Cancer Survivors: A Review

  2021cites this paper
• Clinical Outcome of paediatric ewing sarcoma and significance of pathological necrosis for mortality after neoadjuvant chemotherapy: Single institutional study.

  2021cites this paper
• Genome-Wide Sex and Gender Differences in Cancer

  2020cites this paper
• Effects of different treatments and other factors on the prognosis of patients with ewing sarcoma

  2020cites this paper
• Sex differences in cancer chemotherapy effects, and why we need to reconsider BSA-based dosing of chemotherapy

  2020cites this paper
• Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology.

  2018cites this paper
• Investigating the heterogeneity of alkylating agents’ efficacy and toxicity between sexes: A systematic review and meta‐analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)

  2017cites this paper
• Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow

  2016cites this paper
• Ewing sarcoma and the new emerging Ewing-like sarcomas: (CIC and BCOR-rearranged-sarcomas). A systematic review.

  2016cites this paper
• [Cancer in adolescents and young adults in France: Epidemiology and pathways of care].

  2016cites this paper
• Systemic therapy for bone sarcomas

  2016cites this paper
• Drugs that Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs

  2015cites this paper
• Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients

  2014cites this paper